StonvexLoading…
StonvexStonvexStonvexCore line items from VIAV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-28 | Q4 2025 2025-12-27 | Q3 2025 2025-09-27 | Annual 2025 2025-06-28 |
|---|---|---|---|---|---|
Revenue | $438.15M | $1.08B | $668.40M | $299.10M | $1.08B |
Operating Income | Not available | $43.80M | $19.00M | $7.60M | $57.50M |
Net Income | Not available | $-63.10M | $-69.50M | $-21.40M | $34.80M |
EPS (Diluted) | $0.30 | $-0.28 | $-0.31 | $-0.10 | $0.15 |
Total Assets | Not available | $2.53B | $2.78B | $2.08B | $1.99B |
Total Liabilities | Not available | $1.68B | $1.94B | $1.36B | $1.21B |
Cash & Equivalents | Not available | $499.00M | $765.50M | $543.80M | $423.60M |
Free Cash Flow OCF − CapEx | Not available | $27.20M | $59.40M | $22.50M | $62.00M |
Shares Outstanding | Not available | 234.00M | 231.00M | 223.00M | 223.00M |